You just read:

Nouscom Demonstrates Preclinical Proof of Concept for Personalized Cancer Neoantigen Vaccine in Combination With Immune Checkpoint Blockade to Eradicate Large Tumors

News provided by

Nouscom

19 Jun, 2019, 11:30 BST